165 related articles for article (PubMed ID: 30360374)
1. Choline Kinase Alpha Inhibition by EB-3D Triggers Cellular Senescence, Reduces Tumor Growth and Metastatic Dissemination in Breast Cancer.
Mariotto E; Viola G; Ronca R; Persano L; Aveic S; Bhujwalla ZM; Mori N; Accordi B; Serafin V; López-Cara LC; Bortolozzi R
Cancers (Basel); 2018 Oct; 10(10):. PubMed ID: 30360374
[TBL] [Abstract][Full Text] [Related]
2. EB-3D a novel choline kinase inhibitor induces deregulation of the AMPK-mTOR pathway and apoptosis in leukemia T-cells.
Mariotto E; Bortolozzi R; Volpin I; Carta D; Serafin V; Accordi B; Basso G; Navarro PL; López-Cara LC; Viola G
Biochem Pharmacol; 2018 Sep; 155():213-223. PubMed ID: 30006194
[TBL] [Abstract][Full Text] [Related]
3. Choline kinase-α protein and phosphatidylcholine but not phosphocholine are required for breast cancer cell survival.
Mori N; Wildes F; Kakkad S; Jacob D; Solaiyappan M; Glunde K; Bhujwalla ZM
NMR Biomed; 2015 Dec; 28(12):1697-706. PubMed ID: 26503172
[TBL] [Abstract][Full Text] [Related]
4. Differential role of human choline kinase alpha and beta enzymes in lipid metabolism: implications in cancer onset and treatment.
Gallego-Ortega D; Ramirez de Molina A; Ramos MA; Valdes-Mora F; Barderas MG; Sarmentero-Estrada J; Lacal JC
PLoS One; 2009 Nov; 4(11):e7819. PubMed ID: 19915674
[TBL] [Abstract][Full Text] [Related]
5. Anticancer Activity of the Choline Kinase Inhibitor PL48 Is Due to Selective Disruption of Choline Metabolism and Transport Systems in Cancer Cell Lines.
García-Molina P; Sola-Leyva A; Luque-Navarro PM; Laso A; Ríos-Marco P; Ríos A; Lanari D; Torretta A; Parisini E; López-Cara LC; Marco C; Carrasco-Jiménez MP
Pharmaceutics; 2022 Feb; 14(2):. PubMed ID: 35214160
[TBL] [Abstract][Full Text] [Related]
6. Choline kinase inhibitors EB-3D and EB-3P interferes with lipid homeostasis in HepG2 cells.
Sola-Leyva A; López-Cara LC; Ríos-Marco P; Ríos A; Marco C; Carrasco-Jiménez MP
Sci Rep; 2019 Mar; 9(1):5109. PubMed ID: 30911014
[TBL] [Abstract][Full Text] [Related]
7. Imperatorin suppresses proliferation and angiogenesis of human colon cancer cell by targeting HIF-1α via the mTOR/p70S6K/4E-BP1 and MAPK pathways.
Mi C; Ma J; Wang KS; Zuo HX; Wang Z; Li MY; Piao LX; Xu GH; Li X; Quan ZS; Jin X
J Ethnopharmacol; 2017 May; 203():27-38. PubMed ID: 28341244
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of mTORC1 signaling reduces tumor growth but does not prevent cancer progression in a mouse model of thyroid cancer.
Guigon CJ; Fozzatti L; Lu C; Willingham MC; Cheng SY
Carcinogenesis; 2010 Jul; 31(7):1284-91. PubMed ID: 20299527
[TBL] [Abstract][Full Text] [Related]
9. Choline kinase alpha depletion selectively kills tumoral cells.
Bañez-Coronel M; Ramírez de Molina A; Rodríguez-González A; Sarmentero J; Ramos MA; García-Cabezas MA; García-Oroz L; Lacal JC
Curr Cancer Drug Targets; 2008 Dec; 8(8):709-19. PubMed ID: 19075594
[TBL] [Abstract][Full Text] [Related]
10. Novel 4-amino bis-pyridinium and bis-quinolinium derivatives as choline kinase inhibitors with antiproliferative activity against the human breast cancer SKBR-3 cell line.
Gómez-Pérez V; McSorley T; See Too WC; Konrad M; Campos JM
ChemMedChem; 2012 Apr; 7(4):663-9. PubMed ID: 22278967
[TBL] [Abstract][Full Text] [Related]
11. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
12. Cryptotanshinone activates AMPK-TSC2 axis leading to inhibition of mTORC1 signaling in cancer cells.
Chen W; Pan Y; Wang S; Liu Y; Chen G; Zhou L; Ni W; Wang A; Lu Y
BMC Cancer; 2017 Jan; 17(1):34. PubMed ID: 28061838
[TBL] [Abstract][Full Text] [Related]
13. Phorbol ester stimulation of phosphatidylcholine synthesis requires expression of both protein kinase C-alpha and phospholipase D.
Kiss Z; Crilly KS; Anderson WH
Biochim Biophys Acta; 1998 May; 1392(1):109-18. PubMed ID: 9593849
[TBL] [Abstract][Full Text] [Related]
14. Antiproliferative and antimetastatic properties of 3-benzyloxy-16-hydroxymethylene-estradiol analogs against breast cancer cell lines.
Sinka I; Kiss A; Mernyák E; Wölfling J; Schneider G; Ocsovszki I; Kuo CY; Wang HC; Zupkó I
Eur J Pharm Sci; 2018 Oct; 123():362-370. PubMed ID: 30010030
[TBL] [Abstract][Full Text] [Related]
15. Near infrared fluorescent imaging of choline kinase alpha expression and inhibition in breast tumors.
Arlauckas SP; Kumar M; Popov AV; Poptani H; Delikatny EJ
Oncotarget; 2017 Mar; 8(10):16518-16530. PubMed ID: 28157707
[TBL] [Abstract][Full Text] [Related]
16. Embelin Inhibits Invasion and Migration of MDA-MB-231 Breast Cancer Cells by Suppression of CXC Chemokine Receptor 4, Matrix Metalloproteinases-9/2, and Epithelial-Mesenchymal Transition.
Lee H; Ko JH; Baek SH; Nam D; Lee SG; Lee J; Yang WM; Um JY; Kim SH; Shim BS; Ahn KS
Phytother Res; 2016 Jun; 30(6):1021-32. PubMed ID: 27030214
[TBL] [Abstract][Full Text] [Related]
17. Key Players in Choline Metabolic Reprograming in Triple-Negative Breast Cancer.
Iorio E; Caramujo MJ; Cecchetti S; Spadaro F; Carpinelli G; Canese R; Podo F
Front Oncol; 2016; 6():205. PubMed ID: 27747192
[TBL] [Abstract][Full Text] [Related]
18. Anticancer properties of pomolic acid-induced AMP-activated protein kinase activation in MCF7 human breast cancer cells.
Youn SH; Lee JS; Lee MS; Cha EY; Thuong PT; Kim JR; Chang ES
Biol Pharm Bull; 2012; 35(1):105-10. PubMed ID: 22223345
[TBL] [Abstract][Full Text] [Related]
19. Pharmacodynamic markers for choline kinase down-regulation in breast cancer cells.
Nimmagadda S; Glunde K; Pomper MG; Bhujwalla ZM
Neoplasia; 2009 May; 11(5):477-84. PubMed ID: 19412432
[TBL] [Abstract][Full Text] [Related]
20. [10]-Gingerol Affects Multiple Metastatic Processes and Induces Apoptosis in MDAMB- 231 Breast Tumor Cells.
Fuzer AM; Martin ACBM; Becceneri AB; da Silva JA; Vieira PC; Cominetti MR
Anticancer Agents Med Chem; 2019; 19(5):645-654. PubMed ID: 30370858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
